AdBio Partners
AdBio partners, founded in 2016 and based in Paris, France, is a venture capital firm specializing in early-stage investments in promising life sciences startups across Europe. It focuses on building pioneering healthcare companies by partnering closely with scientific founders and academic institutions, providing both capital and entrepreneurial support.
Key facts
Recent exits
Coverage notes
2 funds tracked, 27 portfolio companies (25 active · 2 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
27 companiesFunds & portfolio
Every fund AdBio Partners has raised, with its portfolio companies. Hand-checked from public filings.
AFB Fund IIVC2021 · 5yr€86M17 active
Unrealized
17 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare |  France | 2024 | |
| Healthcare | France | 2025 | |
| Healthcare | France | 2023 | |
| Healthcare | France | 2023 | |
| Biotech |  Belgium | 2019 | |
| Healthcare | France | 2023 | |
| Healthcare |  Denmark | 2025 | |
| Healthcare |  Ireland | 2021 | |
| Biotech | France | 2020 | |
| Biotech |  Germany | 2025 | |
| Biotech | France | 2021 | |
| Healthcare | France | 2023 | |
| Biotech |  Spain | 2026 | |
| Healthcare | France | 2021 | |
| Biotech |  UK | 2023 | |
| Healthcare | France | 2021 | |
| Biotech | Belgium | 2022 |
France· Entry 2024France· Entry 2025France· Entry 2023France· Entry 2023Belgium· Entry 2019France· Entry 2023Denmark· Entry 2025Ireland· Entry 2021France· Entry 2020Germany· Entry 2025France· Entry 2021France· Entry 2023Spain· Entry 2026France· Entry 2021UK· Entry 2023France· Entry 2021Belgium· Entry 2022AFB Seed-FundVC2017 · 9yr€47M8 active · 2 realized
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare | France | 2020 | |
| Biotech | Spain | 2020 | |
| Healthcare | France | 2020 | |
| Biotech | France | 2019 | |
| Healthcare | France | 2019 | |
| Healthcare | France | 2019 | |
| Healthcare | France | 2020 | |
| Healthcare | France | 2019 |
France· Entry 2020Spain· Entry 2020France· Entry 2020France· Entry 2019France· Entry 2019France· Entry 2019France· Entry 2020France· Entry 2019Realized
2 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Biotech | Belgium | 2019 | 2026 | IPO | – | ||
| Biotech | France | 2020 | 2021 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About AdBio Partners
AdBio partners is a French venture capital firm with €133 million of assets under management, founded in 2016 and headquartered in Paris. The firm specialises in early-stage investments in promising life sciences startups across Europe, focusing on building pioneering healthcare companies by partnering closely with scientific founders and management teams.
Investment thesis
AdBio Partners targets European life sciences startups at seed and Series A-B stages, with sector focus on biotech (drug discovery and development), MedTech and selective HealthTech verticals. Equity ticket sizes typically range from €1 million seed positions through to €10 million Series A-B follow-on commitments. The life sciences-exclusive mandate enables deep scientific and clinical expertise across portfolio companies, distinguishing AdBio from generalist VC peers.
Recent activity
Recent realised exits include Agomab Therapeutics (healthcare, 2026) and Univercells (biotech, 2024), reflecting active distribution across the life sciences portfolio. The platform tracks 2 funds, 20 active portfolio companies and 2 realised exits across the multi-vintage European life sciences programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€132M
France·€134M
France·€132M
France·€135M
France·€130M
France·€130M
France·€137M
France·€140M
France·€140M
France·€125M
France·€146M
France·€120MGet the full picture on AdBio Partners.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in